ITGAM and infection: We found that administration of G-CSF/anti-G-CSF mAb complexes during the first three days of infection did not alter the kinetics of the CD8+ T cell response (Figure 3B), despite a nearly 3-fold increase in the percentage of CD11b+Gr-1+ myeloid cells in the peripheral blood (Figure 3C, D).